Ceres (CERE) Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon Apr 13, 2021 06:33AM
Cerevel Therapeutics Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon Apr 13, 2021 06:30AM
Cerevel Therapeutics Announces the Appointments of Deval Patrick and Deborah Baron to its Board of Directors Jan 21, 2021 07:00AM
Cerevel Therapeutics Debuts as Publicly Traded Neuroscience Company Oct 28, 2020 07:00AM